Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Debt to Equity (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Debt to Equity for 4 consecutive years, with $0.32 as the latest value for Q3 2025.

  • On a quarterly basis, Debt to Equity changed N/A to $0.32 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.32, a N/A change, with the full-year FY2024 number at $0.43, changed N/A from a year prior.
  • Debt to Equity was $0.32 for Q3 2025 at Orchestra BioMed Holdings, down from $48.76 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $48.76 in Q2 2025 to a low of $0.1 in Q1 2023.
  • A 4-year average of $6.36 and a median of $0.27 in 2022 define the central range for Debt to Equity.